Timothy G. Dixon

President & Chief Executive Officer at Therapeutic Solutions International, Inc.

Timothy G. Dixon

Timothy G. Dixon

President & Chief Executive Officer at Therapeutic Solutions International, Inc.

Overview
Career Highlights

MolecuVax, Inc.
MxThree Dimensional Media Ic
OmniBiome, Inc.

RelSci Relationships

20

Number of Boards

4

Birthday

1959

Age

59

Relationships

Former Vice President, Chief Financial Officer & Secretary at Therapeutic Solutions International, Inc.

Co-Founder at Batu Biologics, Inc.

Chief Scientific Officer & Director at Capo Therapeutics, Inc.

President & Chief Scientific Officer at Regen BioPharma, Inc.

Director at Capo Therapeutics, Inc.

Director-Neuro-Oncology at Moores UCSD Cancer Center

Chairman & Research Director at Vaxine Pty Ltd.

Director at Capo Therapeutics, Inc.

Chief Executive Officer at OmniBiome, Inc.

Chief Executive Officer at Splint Decisions, Inc.

Subscribe to RelSci Professional to see 20 more Relationships
Paths to Timothy G. Dixon
Potential Connections via
Relationship Science
You
Timothy G. Dixon
President & Chief Executive Officer at Therapeutic Solutions International, Inc.
Career History
Chairman & President
2015 - Current

MolecuVax, Inc. manufactures biopharmaceutical products. It offers MVAX-001, a cancer stem cell targeted immunotherapy that activates the immune system to seek and destroy cancer stem cells based on their expression of a protein named Brother of the Regulator of Imprinted Sites (BORIS). The company is headquartered in Oceanside, CA.

President
2004 - Current
President & Chief Executive Officer
Current

Therapeutic Solutions International, Inc. develops, produces, and markets technologies and cost-effective therapeutic modalities for the treatment and prevention of common neurologic, sleep, and temporomandibular disorders. It develops immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The company was founded on August 6, 2007 and is headquartered in Oceanside, CA.

Subscribe now for extended career history
Boards & Committees
Chairman & President
2015 - Current

MolecuVax, Inc. manufactures biopharmaceutical products. It offers MVAX-001, a cancer stem cell targeted immunotherapy that activates the immune system to seek and destroy cancer stem cells based on their expression of a protein named Brother of the Regulator of Imprinted Sites (BORIS). The company is headquartered in Oceanside, CA.

Chairman
Current

Therapeutic Solutions International, Inc. develops, produces, and markets technologies and cost-effective therapeutic modalities for the treatment and prevention of common neurologic, sleep, and temporomandibular disorders. It develops immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The company was founded on August 6, 2007 and is headquartered in Oceanside, CA.

Chairman & President
Current

OmniBiome, Inc. manufactures diagnostic kits. It focuses on developing Dx/Rx products and services for pre-pregnancy-associated and pregnancy-associated conditions or diseases where there is a substantive putative link with microbiome dysbiosis, as well as on restoring eubiosis. The company is headquartered in Oceanside, CA.

Subscribe now to see 1 more corporate board memberships
Subscribe now to see non-profit board memberships for over 7 million people
Subscribe now to see government board memberships for over 7 million people
Public Holdings
Restricted data only for RelSci Professional users.
Subscribe now to see public holdings for over 7 million people